Teoxane has been awarded Deloitte’s “Switzerland’s Best Managed Companies” prize for the fourth consecutive year and has achieved the exclusive Gold status.

Teoxane, a leading player in the development of aesthetic solutions and a range of hyaluronic acid-based skincare products, has once again been recognised by Deloitte in the 2026 edition of the Switzerland’s Best Managed Companies programme. The ceremony took place in Zurich on 25 June 2026.

Geneva, 26 June 2026,

Teoxane has been awarded Deloitte’s “Switzerland’s Best Managed Companies” prize for the fourth consecutive year and has achieved the exclusive Gold status.

With this fourth consecutive award, Teoxane has been awarded Gold status — a rare honour granted only to companies that have demonstrated consistent managerial excellence over four consecutive years. This status confirms Teoxane’s place within a prestigious network of exceptional private companies on an international scale.

Whilst the international environment remains unstable, Teoxane is continuing to grow and strengthening its position in the hyaluronic acid injectables market. This recognition is a testament to the strength of a business model based on rigorous governance, a long-term strategy, and an agile and disciplined approach to execution.

Teoxane’s strategy is based on a number of key pillars:

Continuous innovation to anticipate market needs,

Relying on cutting-edge scientific rigour to develop safe and effective solutions,

Ensuring patient safety and practitioner satisfaction,

Striving for excellence at all levels of the organisation, on a global scale.

Innovation remains a key driver of growth. The launch of Teoxane babyGLOW™ at IMCAS Paris 2026 illustrates this ambition: a rapid and reproducible 8-point injection protocol, designed to meet practitioners’ practical expectations whilst delivering visible results — an immediate glow and a gradual improvement in skin quality. Teoxane is thus establishing a distinctive position in a high-potential segment.

On the international stage, Teoxane is reaching new milestones. In January, Teoxane opened a regional academy in Thailand, designed to provide rigorous and ongoing training for practitioners in this strategic region – a regional hub for medical aesthetics – thereby reinforcing its commitment to international medical education.

At the same time, the company is accelerating its expansion into the US market, having reached another major milestone with the FDA’s approval of RHA Redensity® Eye for infraorbital use, thereby consolidating our presence in a key market.

“Achieving Gold status is no accident. It is the result of rigorous work and a commitment to high standards maintained year after year, and I would like to acknowledge the contribution of all our teams. This level of recognition becomes increasingly difficult to achieve as we progress, which makes this distinction particularly significant. The past twelve months have also been marked by tangible progress: the launch of new formulations, a new lip product, and the Teoxane babyGLOW™ protocol, which has already surpassed 140,000 treatments worldwide. All of this demonstrates that our commitment to excellence translates into real results.” Valérie Taupin, Chairwoman, Chief Executive and Founder of Teoxane

The Switzerland awards are derived from Deloitte’s global Best Managed Companies awards programmes – an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, and innovation, governance and financial performance. Applicants are evaluated by an independent panel of judges. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide.

The Best Managed Companies programme is an initiative of Deloitte Private, in collaboration with EFG Private Banking, SIX Swiss Exchange, Zurich Chamber of Commerce and WillisHenry.

«The companies that won the Best Managed Companies Award have every right to be proud: they have undergone an intensive evaluation process and have impressively demonstrated that they manage their company in an exemplary manner in each of the four key entrepreneurial areas — strategy, productivity & innovation, culture & commitment and governance & finance», emphasises Andreas Bodenmann, Best Managed Companies Programme Leader at Deloitte Switzerland.

About Switzerland’s Best Managed Companies

Switzerland’s Best Managed Companies programme is an awards programme recognising privately held companies for their organisational success and achievement. The programme provides a distinct framework for management teams to challenge themselves and benchmark against some of the best private companies in the world.

The Best Managed Companies programme was established in 1993 in Canada and has become the most significant business award of its kind. The programme is active in 50+ countries across the Americas, Europe and Australasia.

For more information on the awards programme, visit the Switzerland Best Managed Companies website www.bestmanagedcompanies.ch

About Teoxane 

Established in 2003 in Switzerland by Founder and CEO Valérie Taupin, Teoxane specializes in developing aesthetic solutions based on hyaluronic acid. With over 20 years of expertise, the company is recognized as a pioneer in the science of facial beauty.  Built as an independent company, Teoxane was founded on a clear vision: to expand the possibilities of aesthetic treatments through high-performance dermal fillers, skin boosters, and skincare, all developed through rigorous scientific research and a constant pursuit of excellence.  Through close collaboration with the global medical community, a strong focus on education, and an uncompromising commitment to safety, Teoxane contributes to advancing aesthetic medicine toward higher standards, one where subtle procedure can deliver a meaningful impact on patients’ self-image and overall well-being.  

Inject more beauty into your life. 

www.teoxane.com 

Contact Relations Presse
Norah Bourama – Global Communication Manager
n.bourama@teoxane.com